Comparison of clinical results of two pharmaceutical products of riboflavin in corneal collagen cross-linking for keratoconus.

Daru · 2014 · PMC4001359 · PMID 24713424

Europe PMC DOI

hedged sentences

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

borderline significantP = 0.057so close (0.05 < p ≤ 0.1)

The decrease in CH between the two groups was borderline significant (P = 0.057).

also in 11,409 other papers

a decreasing trendno p-value reported

Despite an increase in max-K in the first follow up, it had a decreasing trend thereafter.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.